Collectively, our findings emphasize the NF–SPRED2 axis as a potential novel therapeutic target, and strategies aimed at restoring or enhancing its function may offer novel approaches for the prevention and treatment of BC, particularly TNBC. The gene discussed is SPRED2; the disease is breast cancer.